Introduction
High levels of sedentary behavior, particularly regular prolonged exposure to sitting, may increase the risk of lower-extremity vascular arterial and venous complications, including deep vein thrombosis (DVT).
1–3 For example, the risk of DVT is four times higher in older adults with a sedentary lifestyle,
1 and 2.8 times higher in younger and middle-aged adults who sit for prolonged periods at work.
2 Considering one in 12 middle-aged adults will develop DVT in their lifetime,
4 and that the prevalence of sedentary behavior is increasing,
5 identifying simple strategies to mitigate the risks associated with repeated exposure to prolonged sitting is important. One strategy is the use of simple physical activities such as walking breaks to interrupt prolonged sitting, which has been reported to decrease or prevent impaired leg arterial function.
6 However, such strategies may not be suitable for use in all contexts (e.g. some work environments), or for all populations (e.g. those confined to bedrest or wheelchairs). A strategy which may compliment or serve as an alternative to physical activities is the use of compression garment stockings (CGS).
For both venous and arterial complications, an important contributory factor may be blood pooling in the lower extremities.
7 Blood pools due to increased hydrostatic pressure, and is augmented when the muscle pump is not regularly activated to aid venous return.
8 On the venous side, the blood pooling results in venous stasis, which increases the risk of blood clotting and subsequent DVT.
9 On the arterial side, the decreased venous return compromises stroke volume
10 and leads to decreased leg blood flow-induced shear stress, the stimulus for maintaining endothelial function.
11 Indeed, a meta-analysis of 17 studies (
n = 269) indicated that uninterrupted sitting decreased leg flow-mediated dilation (FMD), a measure of macrovascular endothelial function, by 2.4%.
12 Additionally, prolonged sitting reduced leg microvascular function, assessed using reactive hyperemia, by ~40–90%.
13 Minimizing blood pooling may reduce the negative effects of prolonged sitting on the lower-extremity venous and arterial systems.
Activating the muscle pump is likely the most effective strategy for preventing blood pooling. However, as discussed above, this strategy may not always be a viable option. Alternatively, the use of CGS attenuated blood pooling compared to a control condition (~165% vs ~71% increase, respectively) when young, health males were asked to stand.
14 Additionally, wearing CGS while standing mitigated the decrease in stroke volume compared to standing without CGS.
15 However, no studies have investigated whether wearing CGS mitigates lower-extremity venous and arterial complications when inactive adults sit for a prolonged period. Therefore, the aim of the present study was to investigate the effects of uninterrupted prolonged (3 hours) sitting, with CGS and without CGS (CON), on the lower-limb venous and arterial system. More specifically, three specific aims where addressed: (i) does the use of CGS help to prevent blood pooling (increased medial gastrocnemius hemoglobin); (ii) does blood pooling correlate decreased stroke volume; and (iii) does the use of CGS preserve lower-limb macrovascular (popliteal artery FMD) and microvascular (popliteal artery reactive hyperemia) function.
Methods
This study is reported in accordance with CONSORT (Consolidated Standards of Reporting Trials) guidelines.
16 All study procedures were approved by the ethical committee of the Mount Fuji Research Institute and were performed in accordance with the guidelines of the Declaration of Helsinki (ECMFRI-02-2017). All participants provided written informed consent prior to participating in the study.
Participants
We recruited healthy men and women between the ages of 18 and 30 years. Exclusion criteria included pregnancy, regular engagement in moderate-to-vigorous physical activity such as jogging, running, stationary bike use (120 ⩾ min/week), current smoker, any known cardio-metabolic disorders, or use of medications known to affect cardiovascular health.
Experimental design
As shown in
Figure 1, this study was a randomized, controlled cross-over trial with two experimental conditions: prolonged (3 hours) sitting (i) without use of CGS (CON), and (ii) with use of CGS. Participants were stratified by sex and randomized to CON or CGS using a lottery. Participants reported to the laboratory on three occasions: one familiarization visit and two experimental visits. A minimum of 2 days separated visits to minimize potential carryover effects (e.g. blood pooling in the lower limbs), with a maximum of 4 days to minimize within-subject variation.
For the experimental visits, participants arrived between 07:00 and 11:00, and at the same time for between-visits. Participants were asked to fast for 12 hours, consuming only water, and having refrained from supplement intake that morning. Additionally, participants were asked to avoid strenuous physical activity and alcohol for 24 hours prior to experimentation. Experimental procedures were conducted in a quiet, environmentally controlled room. After being asked to empty their bladder, participants were asked to rest supine for at least 20 minutes while being connected to measurement devices to assess heart rate and beat-to-beat mean arterial pressure (MAP). Following instrumentation, calf circumference, popliteal artery FMD, and reactive hyperemia were assessed in the prone position in accordance with a published report.
17 Subsequently, participants were positioned in a comfortable chair and near infrared spectroscopy (NIRS) (BOM-L1TRW; Omegawave, Tokyo, Japan) probes were attached to enable continuous assessment of blood pooling.
18–20 Participants remained in the seated posture for 3 hours. They were allowed to use their arms to read or use a laptop, but their feet were placed on a non-slip mat to help keep feet in place and avoid muscle contraction. Study personnel monitored the participants to ensure they remained seated and did not fidget.
Following the sitting bout, calf circumference was re-assessed and then the participants were returned to the bed and placed in the prone position. The participants were carried by the study personnel to the bed in order to avoid leg muscle contraction and to maintain the sitting-induced effects on hemodynamics. Following 5 minutes of quiet rest, popliteal FMD was re-assessed.
Compression garment stocking
The length of the stocking was from the top of the instep to below the knee. The applied pressure of the graduated compression stockings was 29 hPa at the ankle and 20 hPa at the calf. Several sizes of stockings were prepared, and an appropriate garment was selected for each participant according to their ankle width.
Experimental measures
Aim 1: calf blood volume
Blood pooling was assessed using the total hemoglobin (tHb) and deoxygenated hemoglobin (HHb) signals from continuous-wave NIRS (BOM-L1TRW; Omegawave)
7,21 and by measuring calf circumference. Bilateral calf circumference was measured at the widest point of the calf using a non-elastic tape, with the participant in the upright seated position, and marked for repeat measurements. The NIRS probe was placed unilaterally along the vertical plane of the central belly of the medial gastrocnemius at the position of maximum circumference,
18–20 proximal to the CGS. The location was marked, and between-visits participants were asked to re-mark themselves each day to ensure identical site placement. Subcutaneous adiposity and muscle thickness at this site were assessed using B-mode ultrasound (Logic-E; GE Healthcare, Tokyo, Japan).
The continuous-wave NIRS instrument emits infra-red wavelengths of 780, 810, and 830 nm to detect relative tissue levels of oxygenated and deoxygenated hemoglobin (HHb), the total of which is tHb. Whereas tHb reflects blood pooled on both the arterial and venous, the predominant continuation to HHb is likely the venous compartment.
22 The three wavelengths were emitted from two transmitters at 2 cm (detector 1) and 4 cm (detector 2) from the photodiode detector, allowing for a theoretical penetration distance of up to 2 cm.
23 The hemoglobin concentrations received by detector 1 were subtracted from those received by detector 2 to minimize the influence of skin blood flow.
24 A path-length factor of 4.0 was used to correct for photon scattering within the tissue.
20 Considering the device uses continuous-wave NIRS, the scattering of light in tissue cannot be measured and therefore only relative changes in hemoglobin concentration can be detected.
25 NIRS values are presented as percentages from the resting baseline.
20 The use of continuous-wave NIRS for measuring blood pooling is reliable (intraclass correlation coefficients: 0.75).
7Aim 2: central hemodynamics
Heart rate was measured continuously using a standard lead II electrocardiogram (Daily Care BioMedical, Chungli, Taiwan) and beat-by-beat MAP was determined using finger photoplethysmography (MUB-101; MediSens Inc., Tokyo, Japan) placed on the middle or index finger of the left hand
20 at a sampling frequency of 200 Hz using rate of using a commercially available analog-to-digital converter (es8; TEAC, Tokyo, Japan). Additionally, stroke volume was estimated using the Modelflow method
26 and cardiac output was calculated by multiplying stroke volume by heart rate.
Aim 3: leg arterial flow-mediated dilation and reactive hyperemia response
To evaluate FMD and reactive hyperemia responses, a custom-made tourniquet was placed approximately 5 cm distal to the popliteal fossa on the nondominant leg and inflated to 220 mmHg using a custom device. Popliteal artery diameter and shear rate was measured using brightness-mode imaging and pulsed Doppler waveforms, captured using a 10 mHz linear array probe (Logic-e; GE Healthcare). The probe was placed distal to the popliteal fossa while the participant rested in the prone position, with the leg being held in place using a vacuum pack to prevent movement (Vacform; Muranaka Medical Instruments Co. Ltd, Osaka, Japan). The probe placement position was marked within and between-visits and participants were asked to re-mark themselves each day to ensure identical probe placement. The insonation angle was kept constant between 45° and 60° and the sample volume included most of the vessel. Using a commercial video capture device (AMCap; Microsoft, WA, USA), recordings were made for 2 minutes at baseline and then from 30 seconds prior to tourniquet deflation and continued for 3 minutes post-tourniquet deflation. The videos were analyzed offline using custom-designed edge detection and wall-tracking software (version 2.0.1, S-13037, Takei Kiki Kogyo, Japan).
27 FMD (%) was calculated as:
where DBase is the mean diameter averaged over 2 minutes preceding the cuff inflation period, and DPeak is the peak diameter recorded in response to reactive hyperemia.
For microvascular reactivity, area under the curve (AUC) means hyperemic blood flow (blood flow
AUC) and shear rate
AUC were calculated from cuff release to the point of peak diameter to capture the entire hyperemic response above baseline. AUC measures were calculated using the sum of trapezoids method. Blood flow (mL/min) was calculated as (3.14 × mean velocity × [artery diameter/2]
2 × 60) and shear rate (s
−1) as (4 × mean velocity/artery diameter). Resting blood flow is also presented.
Sample size
Previously, we reported that the typical error for change in the tHb signal is 4 μM.
7 To estimate the sample size required to detect the smallest detrimental (or beneficial) effect in a cross-over study
28 with a Type I error rate of 0.05 and 80% power, approximately 18 participants are required to detect a small (2.5 μM) change in tHb. Twenty participants completed the experimental protocol to account for potential missing data.
Statistics
Statistical analyses were performed using the R programming language (RKWard, version 0.7.1; KDE e.V., Berlin, Germeny). Only participants who had complete data for the primary outcomes were included in the analyses. Raw data are presented as mean (SD) and mixed model data are presented as mean (95% CI). Effect size (ES) was calculated as Cohen’s
d where ⩽ 0.2, 0.2, 0.5, and 0.8 were defined as trivial, small, moderate, and large.
29 Correlation (
r) estimates of 0.1, 0.3, and 0.5 were defined as small, medium, and large, respectively.
29To test Aim 1, the effects of time (pre vs post) and condition (CON, CGS) on tHb, HHb, and calf circumference were analyzed using linear mixed models, with random effects of time (slope) and fixed effect of condition. To limit within-subject variance, the models were adjusted for baseline values as specified by Kenward and Roger.
30 To test Aim 2, the effects of time (10, 60, 120, 180 min) and condition (CON, CGS) on central hemodynamic variables were analyzed using linear mixed models, as described above. Intra-individual associations (i.e. change in one measures vs change in the other measure measure) between tHb and HHb with heart rate and estimated stroke volume were analyzed using rmcorr package for R.
31 To test Aim 3, the effects of time (pre vs post) and condition (CON, CGS) on FMD, diameter change (∆D), and blood flow
AUC were analyzed using linear mixed models, as described above. Additionally, to control within-subject variation, ∆D was adjusted for D
Base and shear rate
AUC. The adjustment for D
Base accounted for allometric scaling (i.e. the known dependence of FMD on baseline diameter)
32,33 and shear rate
AUC accounted for the reactive hyperemic shear rate response, which is the vasodilatory stimulus.
34Implications and conclusions
Evidence has demonstrated that prolonged, uninterrupted sitting leads to blood pooling
13,35 and subsequent arterial macrovascular and microvascular dysfunction.
13 The blood pooling may increase the risk of DVT,
9 and the macrovascular and microvascular dysfunction may increase cardiovascular disease risk.
39 The current findings suggest that CGS, a simple and likely highly feasible strategy, decreases blood pooling but does not preserve leg arterial FMD and reactive hyperemia response. As such, CGS may help to protect against DVT risk, but not cardiovascular disease risk. Additional studies are also warranted to better generalize the current findings, including to older generations and the sex-specific effects.